Plasmodium falciparum pre-erythrocytic antigens

Plasmodium falciparum pre-erythrocytic antigens are a group of proteins expressed during the initial stages of the malaria parasite's life cycle, specifically on the surface of sporozoites and within infected hepatocytes (Nunes-Cabaço et al., 2022). The most prominent and clinically validated member is the circumsporozoite protein (CSP), which is essential for sporozoite development, motility, and the invasion of human liver cells (Duffy & Gorres, 2020). Other significant antigens in this class include the thrombospondin-related anonymous protein (TRAP) and liver-stage antigen 1 (LSA-1), which facilitate parasite navigation and intra-hepatic development. These antigens are the primary targets for pre-erythrocytic vaccines, such as RTS,S/AS01 and R21/Matrix-M, which aim to provide sterilizing immunity by blocking the parasite before it reaches the bloodstream (World Health Organization, 2023). By eliciting high titers of neutralizing antibodies and robust T-cell responses, these interventions prevent the establishment of the erythrocytic stage responsible for clinical malaria. However, challenges such as the high genetic diversity of the parasite and the rapid decline of vaccine-induced immunity necessitate ongoing research into multi-antigen and monoclonal antibody-based strategies (ClinicalTrials.gov, 2024).

Other names

Pre-erythrocytic stage antigensSporozoite antigensLiver-stage antigensP. falciparum pre-erythrocytic antigens

Induction of neutralizing antibodies and cellular immune responses to prevent sporozoite invasion of hepatocytes and eliminate liver-stage parasites before they progress to the symptomatic blood stage.